首页 > 市场调查报告书 > 医疗设备

生技设备

基因检测板市场规模、份额和成长分析（按产品/服务、技术、设计和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898579

基因检测板市场规模、份额和成长分析（按产品/服务、技术、设计和地区划分）—产业预测（2026-2033 年）

Gene Panel Market Size, Share, and Growth Analysis, By Product and Services (Test Kits and Testing Services), By Technique (Amplicon-based Approach and Hybridization-based Approach), By Design, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 214 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，基因检测市场规模将达到 34.1 亿美元，到 2025 年将达到 40.7 亿美元，到 2033 年将达到 167 亿美元，在预测期（2026-2033 年）内，复合年增长率将达到 19.3%。

受个人化医疗和基因技术进步的推动，基因组检测市场预计将迎来显着成长。随着基因测序成本的降低，针对多种疾病的全面基因检测变得更加普及，从而满足了遗传性疾病日益增长的趋势以及对个人化治疗方案的需求。基因组检测能够提供关于遗传易感性的宝贵信息，在研究、诊断和治疗方案开发中发挥着至关重要的作用。同时分析多个基因的效率提升，加深了我们对遗传性疾病的理解，并有助于制定个人化的治疗方案。随着生物资讯学和定序技术的不断进步，基因组检测有望变得更加精准，并更深入地融入标准临床工作流程，从而促进其在治疗和预防领域的广泛应用。

基因检测市场驱动因素

基因panel市场主要受次世代定序（NGS）技术进步的推动。 NGS技术能够提高基因分析的准确性、加快处理速度并降低成本。这些创新使得全面的基因组分析成为可能，促进了个人化医疗的发展趋势，并推动了临床和科学研究领域对基因panel的需求。随着NGS技术的不断发展，人们对遗传讯息的理解也日益深入，最终将带来更完善的诊断和治疗策略。这将进一步扩展基因panel在医疗保健和科学研究各领域的应用。

基因检测市场的限制

由于医疗专业人员和患者对基因检测缺乏了解和认识，基因检测市场的发展可能面临挑战。对DNA检测的益处和应用缺乏足够的教育可能会减缓其普及速度，最终影响基因检测市场的成长及其潜在效益。这种认知不足可能会降低医疗服务提供者和患者接受基因检测的意愿，从而影响整体市场潜力，并限制个人化医疗和个人化治疗策略的发展。弥合这些教育差距对于促进市场成长和普及至关重要。

基因检测市场趋势

基因检测市场正经历显着成长，这主要得益于个人化医疗的日益普及。这项转变主要归功于基因组技术的重大进步，医疗服务提供者逐渐认识到基于个别基因组图谱进行治疗的益处，从而实现更精准的诊断和标靶治疗。随着临床医生越来越多地利用基因检测来优化患者照护并改善健康结果，对这些创新工具的需求也日益增长。这一趋势反映了人们为提高治疗效果和减少副作用所做的广泛努力，也使基因检测成为现代医学发展中不可或缺的一部分。

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Qiagen
Roche
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Becton, Dickinson and Company（BD）
Sangamo Therapeutics

简介目录

Product Code: SQMIG35H2314

Gene Panel Market size was valued at USD 3.41 Billion in 2024 and is poised to grow from USD 4.07 Billion in 2025 to USD 16.7 Billion by 2033, growing at a CAGR of 19.3% during the forecast period (2026-2033).

The market for gene panels is poised for significant growth, driven by advancements in personalized medicine and genetic technologies. As genomic sequencing costs decrease, comprehensive genetic testing for various disorders becomes more accessible, catering to the rising prevalence of hereditary diseases and the demand for tailored treatment solutions. Gene panels provide valuable insights into genetic predispositions, making them essential in research, diagnostics, and therapeutic development. Their efficiency in simultaneously analyzing multiple genes enhances understanding of hereditary conditions and aids in developing customized care plans. With ongoing improvements in bioinformatics and sequencing technologies, gene panels are expected to gain greater precision and integration into standard clinical workflows, fostering their increased use in therapeutic and preventive applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gene Panel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gene Panel Market Segments Analysis

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Gene Panel Market

The gene panel market is significantly propelled by advancements in next-generation sequencing (NGS) technologies, which provide enhanced accuracy, faster processing times, and reduced costs for genetic analysis. These innovations facilitate comprehensive genomic profiling, fostering the trend toward personalized medicine and driving the demand for gene panels in both clinical and research settings. As the capabilities of NGS continue to evolve, they enable a deeper understanding of genetic information, ultimately enhancing diagnostic and therapeutic strategies, and further expanding the applicability of gene panels in various areas of healthcare and scientific research.

Restraints in the Gene Panel Market

The growth of the gene panel market may face challenges due to the limited understanding and knowledge of gene panel testing among healthcare professionals and patients. Insufficient education regarding the benefits and applications of DNA panels can result in a slower adoption rate, ultimately influencing the expansion of the genetic testing market and its potential benefits. This lack of awareness can hinder the willingness of both providers and patients to embrace gene panel testing, thereby impacting overall market potential and limiting advancements in personalized medicine and tailored treatment strategies. Addressing these educational gaps is essential for fostering market growth and acceptance.

Market Trends of the Gene Panel Market

The gene panel market is witnessing a significant surge driven by the increasing adoption of personalized medicine, as healthcare providers recognize the benefits of tailoring treatments based on individual genomic profiles. This shift is largely attributed to remarkable advancements in genomic technologies, which facilitate more precise diagnostics and targeted therapies. As clinicians increasingly leverage gene panels to optimize patient care and enhance health outcomes, there is a growing demand for these innovative tools. This trend reflects a broader commitment to enhancing treatment efficacy and minimizing adverse effects, positioning gene panels as essential components in the evolution of modern healthcare.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Pricing Analysis

Global Gene Panel Market Size by Product and Service & CAGR (2026-2033)

Test Kits
Testing Services

Global Gene Panel Market Size by Technique & CAGR (2026-2033)

Amplicon-based Approach
Hybridization-based Approach

Global Gene Panel Market Size byDesign & CAGR (2026-2033)

Predesigned Gene Panel
Customized Gene Panel

Global Gene Panel Market Size byApplication & CAGR (2026-2033)

Cancer Risk Assessment
- Syndrome-specific
- High-penetrance
- High and Moderate-penetrance
- Comprehensive Cancer Risk
Diagnosis of Congenital Diseases
Pharmacogenetics
Other Applications

Global Gene Panel Market Size by End-use & CAGR (2026-2033)

Research and Academic Institutes
Hospital and Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies

Global Gene Panel Market Size & CAGR (2026-2033)

North America, (Product and Services, Technique, Design, Application, End User)
- US
- Canada
Europe, (Product and Services, Technique, Design, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product and Services, Technique, Design, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product and Services, Technique, Design, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product and Services, Technique, Design, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sangamo Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates